Regeneron Pharma (REGN) PT Lowered to $769 at Truist Securities
Truist Securities analyst Greg Renza ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)